Respective risks for mortality and adverse cardiovascular events at the second-highest range in CV+ and CV− patients were narrowly non-significant but increased, while adverse cardiovascular events were significantly increased in the highest CV− haemoglobin category.
← all excerpts
Haemoglobin concentration and survival of haemodialysis patients before and after experiencing cardiovascular disease: a cohort study from Japanese dialysis outcomes and practice pattern study (J-DOPPS).
1
—
—